Press releases

All press releases Regulatory

Regulatory press release 2025-10-08

Xspray Pharma provides update on the FDA process for Dasynoc – observations at contract manufacturer delay approval

Regulatory press release 2025-09-30

New number of shares and votes in Xspray Pharma after new share issue

Regulatory press release 2025-09-11

Xspray’s rights issue oversubscribed – over-allotment issue increased and fully utilized

Regulatory press release 2025-08-26

First day of trading in subscription rights and BTAs moved to August 27

Regulatory press release 2025-08-25

Xspray publishes disclosure document regarding rights issue

All press releases

Latest report
Interim Report Q2 2025
Subscribe
Get our latest press releases and reports
Subscribe
Submit to our press releases and get an email every time we publish a press release or report on our website.
Type*
Reports
Press releases
E-mail*

Välj språk*
Swedish
English
When clicked on Send I agree that my personal information will be saved. Read more
Comments
This field is for validation purposes and should be left unchanged.

Press contact

Jacob Nyberg, IR

+46 70-767 08 83

info@xspray.com

Media